MAP1LC3B and ischemia: The LC3B-II/LC3B-I ratio was increased on day 1 and at 30 days post-ischemia (Figure 4C), which support the LC3B immunoreactivity puncta distribution was significantly increased at 1 and 30 days post-ischemia (Figure 4D) compared with the internal controls.